News Roundup: May 30 to June 3
Your weekly roundup of the latest news from Drug Topics®.
NCPA Announces Support for Bipartisan PBM Transparency Bill
The bill allows state attorneys general and the Federal Trade Commission the ability to initiate legal action against certain PBM business practices.
Is Cephalexin Dosing for Uncomplicated UTIs in the ED Appropriate?
While antibiotic dosing was correct, therapy duration was frequently inappropriate.
The Need for Patient-Specific Medication Optimization Systems
Medication decision support tools focused on individual patients can help pharmacists effectively analyze risk of unintended harm, identify and assess potential interventions, and facilitate longitudinal care.
No Association Between mRNA COVID-19 and Herpes Zoster Identified
Study investigators hope these results are reassuring.
Evaluating the Effectiveness of Naloxone Infusion Therapy for Opioid, Clonidine Ingestion in Children
Current data about naloxone use in pediatric populations is extrapolated from adult studies.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
